Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 6,599,000 | 6,352,000 | 7,389,000 | 7,042,000 | 6,260,000 |
| Cost of Goods | 1,442,000 | 1,401,000 | 1,396,000 | 1,395,000 | 1,442,000 |
| Gross Profit | 5,157,000 | 4,951,000 | 5,993,000 | 5,647,000 | 4,818,000 |
| Operating Expenses | 3,492,000 | 3,247,000 | 3,726,000 | 2,810,000 | 2,789,000 |
| Operating Income | 1,665,000 | 1,705,000 | 2,267,000 | 2,837,000 | 2,029,000 |
| Interest Expense | 230,000 | 230,000 | 226,000 | 229,000 | 242,000 |
| Other Income | 153,000 | -175,000 | -10,000 | -176,000 | -284,000 |
| Pre-tax Income | 1,588,000 | 1,300,000 | 2,031,000 | 2,432,000 | 1,503,000 |
| Income Tax | 549,000 | 316,000 | 398,000 | 646,000 | 368,000 |
| Net Income Continuous | 1,039,000 | 984,000 | 1,633,000 | 1,786,000 | 1,135,000 |
| Minority Interests | -6,000 | -26,000 | -7,000 | -3,000 | -9,000 |
| Net Income | $1,045,000 | $1,011,000 | $1,640,000 | $1,789,000 | $1,144,000 |
| EPS Basic Total Ops | 0.84 | 0.81 | 1.30 | 1.43 | 0.91 |
| EPS Basic Continuous Ops | 0.83 | 0.79 | 1.30 | 1.42 | 0.90 |
| EPS Diluted Total Ops | 0.83 | 0.80 | 1.29 | 1.42 | 0.91 |
| EPS Diluted Continuous Ops | 0.83 | 0.78 | 1.29 | 1.42 | 0.90 |
| EPS Diluted Before Non-Recurring Items | 1.34 | 1.37 | 1.67 | N/A | N/A |
| EBITDA(a) | $2,346,000 | $2,344,000 | $2,795,000 | $3,362,000 | $2,554,000 |